Kazuhiro Sako,Toyohiro Sawada,Keiichi Yoshihara,Hiroyuki Kojima
申请号：
US10842809
公开号：
US08197846B2
申请日:
2004.05.10
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides a sustained-release pharmaceutical composition, characterized in that, there are contained tamsulosin or a pharmaceutically acceptable salt thereof and a carrier for a sustained-release pharmaceutical composition and, when a dissolution test is carried out according to Japanese Pharmacopoeia Dissolution Test Method 2, the tamsulosin release after 7 hours from the start of the dissolution is about 20 to about 85%.
